Table 3 Thromboembolic events and bleeding episodes
From: Prophylactic anticoagulation in nephrotic syndrome prevents thromboembolic complications
TE and bleeding episodes | Anticoagulation | Non-anticoagulation | p-value |
|---|---|---|---|
Number | 44 | 35 | |
Time to TE, (days, IQR) | 22 (7–220) | ||
Thromboembolic events (TE), n (%) | 0 (0) | 4 (12) | 0.035 |
Bleeding episodes, n (%) | 5 (11) | 2 (6) | 0.45 |
Major, n (%) | 2 (5) | 0 (0) | 0.50 |
Minor, n (%) | 3 (7) | 2 (6) | 1.00 |